companydata.dkcompanydata.dk

PharmEng Nordic ApS: Financial statements 2025

CVR: 43181033

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

PharmEng Nordic ApS (CVR 43181033) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 295,768 and a net result of DKK -1,108,665 compared with DKK -876,098 the year before. That is a decrease of 66% compared with the year before. Equity in the 2025 report amounted to DKK -3,162,128. The company had 2 employees in the financial year.

Gross Profit
DKK 295,768
Profit/Loss
DKK -1,108,665
Equity
DKK -3,162,128
Total Assets
DKK 487,365
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-296K-1.1M-3.2M2
2024-870K-876K-2.1M2
2023-583K-941K-1.2M2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PharmEng Nordic ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

PharmEng Nordic ApS: The 2024 annual report is outJul 15, 2025

PharmEng Nordic ApS has published its annual report for 2024. Gross profit came to DKK 870,271, and the net result was DKK -876,098.

Mathieu Charles Louis Roger joins PharmEng Nordic ApS as directorJan 6, 2025

As of January 6, 2025, Mathieu Charles Louis Roger is registered as director of PharmEng Nordic ApS.

Olivier Claude Gillot joins PharmEng Nordic ApS as directorJan 6, 2025

As of January 6, 2025, Olivier Claude Gillot is registered as director of PharmEng Nordic ApS.

Olivier Tambuzzo joins PharmEng Nordic ApS as directorJan 6, 2025

As of January 6, 2025, Olivier Tambuzzo is registered as director of PharmEng Nordic ApS.

Steven Colin Davy steps down as director of PharmEng Nordic ApSJan 6, 2025

As of January 6, 2025, Steven Colin Davy has stepped down as director of PharmEng Nordic ApS.

Alan Kwok-Hung Kwong steps down as director of PharmEng Nordic ApSJan 6, 2025

As of January 6, 2025, Alan Kwok-Hung Kwong has stepped down as director of PharmEng Nordic ApS.

Registered as owner of PharmEng Nordic ApSJan 6, 2025

As of January 6, 2025, is registered as an owner of PharmEng Nordic ApS with an ownership share of 100%.

About PharmEng Nordic ApS

PharmEng Nordic ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2022. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Mathieu Charles Louis Roger, Olivier Claude Gillot and Olivier Tambuzzo. The company is owned by Efor Group SAS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 295,768 and a net result of DKK -1,108,665 compared with DKK -876,098 the year before. Equity in the 2025 report amounted to DKK -3,162,128.

Source: annual report 2025, Danish Business Authority

Other financial years